Company news

iRhythm Holdings, Inc. news in 2024

iRhythm Holdings, Inc.'s news releases, calls and decks from 2024, newest first.

View company

iRhythm Technologies to Present at the 43rd Annual J.P. Morgan Healthcare Conference

December 29, 2024

iRhythm Technologies to Participate in the Citi 2024 Global Healthcare Conference

November 19, 2024

iRhythm Data Presented at the American Heart Association 2024 Scientific Sessions Reinforce Clinical and Health Economic Value of Zio Long-Term Continuous Monitoring

November 17, 2024

iRhythm Technologies to Participate in the Wolfe Research 2024 Healthcare Conference

November 4, 2024

iRhythm Technologies Receives FDA 510(k) Clearance for Design Modifications to Its Zio® AT Device

October 29, 2024

iRhythm Technologies Announces Third Quarter 2024 Financial Results

October 29, 2024

Newly Published Research Shows 14-Day Monitoring Detected Almost Three Times More Nonsustained Ventricular Tachycardia Than Standard 48-Hour Monitoring in Patients with Hypertrophic Cardiomyopathy

October 27, 2024

iRhythm Technologies Receives FDA 510(k) Clearance for Design Updates Previously Made to Its Zio® AT Device

October 20, 2024

iRhythm Technologies to Report Third Quarter 2024 Financial Results on October 30, 2024

October 15, 2024

iRhythm Technologies Announces Japanese Regulatory Approval of the Zio® ECG Monitoring System, the First Product to Deliver Arrhythmia Monitoring Service Utilizing Artificial Intelligence

September 10, 2024

iRhythm Unveils Data Demonstrating Superior Real-World Performance of Next-Generation Zio® Monitor at HRX 2024 Meeting

September 8, 2024

iRhythm Technologies Enters License Agreement with BioIntelliSense for Multiparameter Sensor Technology to be Used in Ambulatory Cardiac Monitoring

September 3, 2024

iRhythm Technologies Announces Results of GUARD-AF Trial

August 31, 2024

iRhythm Technologies Expands Global Reach with the Launch of Zio® Cardiac Arrhythmia Monitoring Service in Austria, the Netherlands, Switzerland, and Spain

August 28, 2024

iRhythm Technologies to Participate in Upcoming Investor Conferences in September

August 20, 2024

iRhythm Technologies Announces Second Quarter 2024 Financial Results

July 31, 2024

iRhythm Technologies Announces Chief Financial Officer Transition

July 31, 2024

iRhythm Technologies to Report Second Quarter 2024 Financial Results on August 1, 2024

July 17, 2024

iRhythm Technologies Achieves Significant Operational Milestone with Launch of Initial Phase of Manufacturing Automation

June 16, 2024

iRhythm Technologies to Present at the 2024 Truist Securities MedTech Conference

June 3, 2024

iRhythm Technologies to Present at the William Blair 44th Annual Growth Stock Conference

May 21, 2024

iRhythm Technologies Announces First Quarter 2024 Financial Results

May 1, 2024

iRhythm Technologies to Report First Quarter 2024 Financial Results on May 2, 2024

April 17, 2024

iRhythm Announces Closing of $661.25 Million of 1.50% Convertible Senior Notes Due 2029, Including Full Exercise of Initial Purchasers’ $86.25 Million Option to Purchase Additional Notes

March 7, 2024

iRhythm Prices Upsized Offering of $575.0 Million of 1.50% Convertible Senior Notes Due 2029

March 3, 2024

iRhythm Announces Proposed Offering of $450.0 Million of Convertible Senior Notes

March 3, 2024

iRhythm collaborates with Epic to streamline access to Zio® service and drive more seamless connectivity between clinicians and patients

February 28, 2024

iRhythm Technologies Announces Fourth Quarter and Full Year 2023 Financial Results

February 21, 2024

iRhythm Technologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024

February 7, 2024

iRhythm Technologies Shares Preliminary Fourth Quarter 2023 Highlights and Business Update at the 42nd Annual J.P. Morgan Healthcare Conference

January 7, 2024

Largest Ever Real-World Evidence Study of Ambulatory Cardiac Monitoring Demonstrates Clinical Superiority of iRhythm's Zio Long-Term Continuous Monitoring Service

January 4, 2024

iRhythm Technologies Receives European Union’s CE Marking Under Medical Device Regulation (EU MDR) for its Zio® monitor and ZEUS System

January 2, 2024

Calls in 2024

Decks in 2024